Gossamer Bio
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $13,799 | $13,294 | $11,489 | $9,889 |
Gross Profit | 13,572 | 13,294 | 11,489 | 9,889 |
EBITDA | -45,813 | -45,467 | -35,316 | -33,550 |
EBIT | -46,040 | -45,473 | -35,529 | -33,892 |
Net Income | -47,238 | -48,221 | -38,273 | -36,638 |
Net Change In Cash | 13,799 | 13,294 | 11,489 | 9,889 |
Free Cash Flow | -48,314 | -36,167 | -47,114 | -39,750 |
Cash | 37,732 | 8,933 | 26,309 | 29,021 |
Basic Shares | 226,604 | 227,981 | 227,275 | 226,818 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $48,471 | $114,701 | $0 | $0 |
Gross Profit | 47,469 | 114,701 | -4,385 | -4,429 |
EBITDA | -162,251 | -39,967 | -161,921 | -211,069 |
EBIT | -163,253 | -44,118 | -166,306 | -215,498 |
Net Income | -170,370 | -56,528 | -179,817 | -229,378 |
Net Change In Cash | 48,471 | 114,701 | 0 | 0 |
Cost of Revenue | -70,977 | |||
Free Cash Flow | -171,345 | -3,468 | -159,158 | -187,507 |
Cash | 37,732 | 46,074 | 32,109 | 111,973 |
Basic Shares | 228,519 | 226,228 | 225,572 | 84,574 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0 |
2025-12-31 | -$0.21 |
2025-09-30 | -$0.21 |
2025-06-30 | -$0.17 |
